SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron
- Supplementary File 1:
ZIP-Document (ZIP, 31 KiB)
Ahmed, S.F.; Quadeer, A.A.; McKay, M.R. SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron. Viruses 2022, 14, 79. https://doi.org/10.3390/v14010079
Ahmed SF, Quadeer AA, McKay MR. SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron. Viruses. 2022; 14(1):79. https://doi.org/10.3390/v14010079
Chicago/Turabian StyleAhmed, Syed F., Ahmed A. Quadeer, and Matthew R. McKay. 2022. "SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron" Viruses 14, no. 1: 79. https://doi.org/10.3390/v14010079